The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 117.50
Bid: 117.50
Ask: 118.00
Change: -0.50 (-0.42%)
Spread: 0.50 (0.426%)
Open: 118.00
High: 118.50
Low: 117.50
Prev. Close: 118.00
RECI Live PriceLast checked at -
Real Estate Credit Investments is an Investment Trust

To provide attractive and stable returns, primarily through quarterly dividends, by exposure to a diversified portfolio of real estate credit investments, predominantly comprising real estate loans and bonds, focusing in UK and Western Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research : Real Estate Credit Investments (RECI) - New faces, same resilience

20 May 2022 16:02

Hardman & Co Research Hardman & Co Research : Real Estate Credit Investments (RECI) - New faces, same resilience 20-May-2022 / 16:02 GMT/BST


Hardman & Co Research: Real Estate Credit Investments – New faces, same resilience

In previous notes, we have repeatedly outlined why we believe RECI shows resilience against inflation, interest rate increases and inflation risk (inter alia, see Experience shows resilience of the model, Experience shows resilience of the model (2) and Why rising rates should not hurt RECI). In this note, we highlight how the recent deals have added to the portfolio, and, as outlined in RECI’s recent quarterly presentation, how they have re-confirmed this protection. We also detail the other key themes from this report, noting the sector and geographical diversity (important when considering exposure to UK rate rises), strong loan to value (LTV) metric, conservative leverage and good counterparty quality.

Please click on the link below for the full report: https://hardmanandco.com/research/corporate-research/new-faces-same-resilience/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick’s Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mark Thomas

+44 (0)203 693 7075

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors’ understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies’ profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1358225 20-May-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
7th Jan 20194:01 pmRNSNotification of Major Interest in Shares
7th Jan 20197:00 amRNSFactsheet Announcement
17th Dec 20189:49 amRNSNotification of Major Interest in Shares
10th Dec 20187:00 amRNSFactsheet Announcement
30th Nov 20187:03 amRNSDividend Declaration
30th Nov 20187:00 amRNSHalf-year Report
29th Nov 20182:23 pmRNSResult of EGM
6th Nov 20187:00 amRNSInv Mngr Fact Sheet and Q2 Investor Presentation
2nd Nov 20183:49 pmRNSPlacing Programme & Notice of EGM
8th Oct 20187:00 amRNSFactsheet Announcement
21st Sep 20183:13 pmRNSClose of Issue of New Ordinary Shares
20th Sep 201810:55 amRNSProposed Issue of New Ordinary Shares
18th Sep 20184:14 pmRNSResult of AGM
5th Sep 20187:00 amRNSFactsheet Announcement
13th Aug 20187:00 amRNSNotice of AGM
9th Aug 20187:00 amRNSDividend Declaration
7th Aug 20187:00 amRNSFact Sheet Annoucement
10th Jul 201810:53 amRNSNotification of Major Interest in Shares
5th Jul 20187:00 amRNSFactsheet Announcement
29th Jun 20183:20 pmRNSDirector Declaration
25th Jun 20184:15 pmRNSDirector/PDMR Shareholding
15th Jun 20187:00 amRNSDividend Declaration
15th Jun 20187:00 amRNSAnnual Financial Report
8th Jun 20189:17 amRNSFactsheet Announcement
1st Jun 20187:00 amRNSUpdate on Share Issue
22nd May 20187:00 amRNSProposed Issue of New Ordinary Shares
4th May 20187:00 amRNSFactsheet Announcement
18th Apr 20187:00 amRNSInvestment Manager Presentation
6th Apr 20187:00 amRNSFactsheet Announcement
19th Mar 20182:54 pmRNSDirector Declaration
9th Mar 20187:00 amRNSFactsheet Announcement
26th Feb 20183:22 pmRNSNotification of Major Interest in Shares
20th Feb 20184:19 pmRNSDividend Declaration
20th Feb 20184:16 pmRNSDirectorate Change
8th Feb 20187:00 amRNSInvestment Manager's Factsheet
8th Jan 20187:00 amRNSFact Sheet Announcement
3rd Jan 20182:35 pmRNSDirectorate Change
2nd Jan 20184:25 pmRNSNotification of Major Interest in Shares
29th Dec 201712:00 pmRNSKey Information Document
27th Dec 20174:03 pmRNSMajor Interest in Shares
27th Dec 20173:59 pmRNSMajor Interest in Shares
27th Dec 20177:00 amRNSNotification of Major Interest in Shares
21st Dec 20175:13 pmRNSDirector/PDMR Shareholding
19th Dec 20174:10 pmRNSNotification of Major Interest in Shares
18th Dec 20173:39 pmRNSNotification of Major Interest in Shares
15th Dec 20173:46 pmRNSClose of Issue of new Ordinary Shares
15th Dec 201712:31 pmRNSProposed Issue of new Ordinary Shares
6th Dec 20177:00 amRNSFact Sheet Announcement
1st Dec 20177:00 amRNSDividend Declaration
1st Dec 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.